SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is trending as the market keenly anticipates a pivotal Department of Energy announcement regarding surplus plutonium awards, a key catalyst for its advanced nuclear technology. Bullish sentiment is driven by expectations of government support and institutional accumulation during a perceived oversold period. Conversely, bears emphasize substantial insider selling and ongoing share dilution, raising concerns about the company's valuation given its current lack of commercial revenue.

Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.

Ekso Bionics Holdings Inc

EKSO is experiencing significant upward momentum and trading volume following the announcement of a proposed business combination with Applied Digital's cloud division, forming a new AI compute platform, ChronoScale. The community is actively discussing this pivot into AI infrastructure, with many anticipating a substantial short squeeze despite lingering concerns about potential dilution. This move highlights EKSO's transformation into a key player in the rapidly expanding AI sector.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust (SLV) is experiencing significant volatility and trending amid intense community debate. A recent sharp rebound from declines, attributed by many to alleged manipulation via margin calls, is fueling discussion of a potential short squeeze. The market is buzzing with anticipation over imminent silver export restrictions from China, effective January 1st, 2026, which bulls believe will profoundly impact supply and drive prices higher due to rising industrial demand.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending fueled by its highly engaged community, passionately advocating for the "OG meme" narrative of Rage Comics and actively building out an ecosystem with tools like RageMaker and RageGames. This dedicated base expresses strong conviction, viewing RAGE as significantly undervalued and poised for substantial long-term growth as they lead a "return to the memes" within the broader market upswing.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending amidst a persistent downtrend that has frustrated many investors, fueling community discussion around market manipulation and the stock's daily declines. Despite this bearish sentiment, bulls highlight the company's international expansion, AI integration, and a share buyback program as strong long-term catalysts. The market is weighing Hims' direct-to-consumer model and GLP-1 strategy, particularly after the FDA approval of Novo Nordisk's oral weight-loss pill, creating a divide between those seeing a buying opportunity and those questioning its immediate prospects.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending due to significant community debate and anticipation surrounding potential positive announcements at the upcoming CES 2026. While many investors express frustration over recent price declines, a bullish contingent highlights analyst upgrades, institutional buying, and the company's strong fundamentals in agentic AI voice solutions for automotive and restaurant sectors, viewing current levels as a strategic buying opportunity for long-term growth.

BUUU Group Ltd. is a holding company, which operates through its subsidiaries, BU Creation and BU Workshop. Its subsidiaries engage in design, planning and production of face-to-face events, immersive environments and brand-based experiences for clients and venues, including event organizers, consumer brand marketers and retail shopping centers. The company was founded in 2017 and is headquartered in Hong Kong.

BUUU Group Ltd. - Ordinary Shares - Class A

BUUU Group Ltd

BUUU Group Ltd is experiencing extreme volatility and intense speculative trading, driven by comparisons to other high-flying, low-float Chinese stocks. While many traders are actively chasing rapid gains, a significant portion of the community warns of a potential pump and dump scenario, fueling a highly divided discussion.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is trending following positive Phase 3 trial data for its relacorilant candidate in platinum-resistant ovarian cancer, sparking community debate over market valuation and intense short-seller activity. Investors are also focused on an upcoming regulatory decision for relacorilant in Cushing's syndrome and promising survival data from its ALS program, fueling discussions about the company's long-term growth and potential for a significant short squeeze.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending with high anticipation for multiple imminent FDA decisions, including a PDUFA date for its motion sickness drug, Tradipitant, and an expedited re-review for Hetlioz in jet lag. The community is actively discussing Tradipitant's significant potential in addressing GLP-1 induced nausea, viewing these regulatory catalysts as crucial for a re-rating given the company's improved relationship with the FDA. Investors are keenly watching for outcomes that could lead to considerable stock movement, drawing comparisons to other recent biotech approvals.

BYTE is a novel meme token that creatively intertwines the worlds of cryptocurrency and popular culture. Inspired by Grok's answer to "What would you name your dog?", Grok answered, 'Byte.' When Grok was asked who created Byte, it says he was created by the xAI team lead by Elon Musk as a gift to Grok AI to keep him company in the metaverse. BYTE serves as a playful reference to the unit of digital information, as well as a nod to the AI's technological nature. Distinctively, Byte acts as a gateway towards Ai adoption and stands out in the crypto space due to its zero-tax policy, a feature that is increasingly appealing to many investors. Additionally, it upholds the principles of transparency and investor trust by having its liquidity permanently burned and the contract ownership renounced. This ensures that Byte remains a community-driven project, with its fate firmly in the hands of its holders. The combination of a playful theme, generative AI, and a nod to a tech icon makes Byte an intriguing addition to the meme token ecosystem, especially AI related meme coins.  Through pioneering AI this story has grown more and more robust and continues to evolve, Byte pledges its dedication to community efforts and and has consistently appeared in the Top 10 of LunarCrush’s social engagement leaderboards on multiple occasions.

BYTE

BYTE is trending as its dedicated community fervently discusses its potential as "Grok's AI dog" or "Elon's AI sidekick," positioning it as the "chosen one" within the digital world. The community widely believes "something big is coming" for this AI-themed memecoin, emphasizing its strong "ByteArmy" and its role as the "future of AI" within the Ethereum ecosystem.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is ISRG's 20% Procedure Growth the New Normal or a Peak?

ISRG posts 20% Q3 procedure growth as da Vinci and Ion volumes accelerate, but investors question if product cycles and timing effects can sustain it.

From Hospitals to ASCs: Will Refurbished Xi Systems Broaden ISRG's Reach?

ISRG leverages refurbished Xi systems to reach cost-sensitive markets and expand access beyond hospitals.

STXS Secures FDA Approval for GenesisX to Broaden Surgical Robotics

Stereotaxis wins FDA clearance for GenesisX, a streamlined robotic system aimed at boosting hospital adoption and accelerating growth.

Stereotaxis Inc. (STXS) Reports Q3 Loss, Misses Revenue Estimates

Stereotaxis (STXS) delivered earnings and revenue surprises of +50.00% and -13.21%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Misses Revenue Estimates

Rapid Micro Biosystems (RPID) delivered earnings and revenue surprises of 0.00% and -0.79%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Mettler-Toledo (MTD) Beats Q3 Earnings and Revenue Estimates

Mettler-Toledo (MTD) delivered earnings and revenue surprises of +4.99% and +3.84%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

LivaNova (LIVN) Tops Q3 Earnings and Revenue Estimates

LivaNova (LIVN) delivered earnings and revenue surprises of +21.98% and +3.92%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Tactile Systems Technology (TCMD) Beats Q3 Earnings and Revenue Estimates

Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of +125.00% and +8.04%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

ISRG Rides on da Vinci 5 Momentum: Can This Growth Sustain?

Intuitive Surgical's Q3 results impress, with da Vinci 5 adoption driving 23% revenue growth, though sustaining this rapid momentum may pose new challenges ahead.

Stereotaxis Rolls Out Synchrony System in EU and Files for FDA Approval

STXS expands its digital surgery vision with the EU launch of its Synchrony System and an FDA submission for market entry.

Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.

STXS
Stereotaxis Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest STXS News

STXSStereotaxis Inc